Cite
APA Citation
Butzkueven, H., Licata, S., Jeffery, D., Arnold, D. L., Filippi, M., Geurts, J. J., Santra, S., Campbell, N., & Ho, P. (2020). natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study. BMJ open, 10(10), . http://access.bl.uk/ark:/81055/vdc_100127576888.0x000040